Erratum: Study of the experimental conditions for the lipase production by a newly isolated strain of Pseudomonas aeruginosa for the enantioselective hydrolysis of (±)-methyl trans-3(4-methoxyphenyl) glycidate (MPGM) (Bioprocess and Biosystem (2005) DOI: 10.1007/s00449-005-0039-7);Study of the experimental conditions for the lipase production by a newly isolated strain of Pseudomonas aeruginosa for the enantioselective hydrolysis of (±)-methyl trans-3(4-methoxyphenyl) glycidate

Bioprocess and Biosystems Engineering

Volumn 28, Issue 5, 2006, Pages 341-348

  Singh, Sawraj ^a   Kaur, Gurmeet ^a   Chakraborti, Asit K ^a   Jain, Rakesh K ^b   Banerjee, Uttam C ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

( ) MPGM; 16S rRNA; Enantiospecific hydrolysis; Lipase; Medium optimization; Pseudomonas aeruginosa

Indexed keywords

CARDIOVASCULAR SYSTEM; CONCENTRATION (PROCESS); CULTIVATION; DRUG DOSAGE; HYDROLYSIS; SOILS; SYNTHESIS (CHEMICAL);

(±)-MPGM; DILTIAZEM; ENANTIOSPECIFIC HYDROLYSIS; INOCULUM; LIPASE; MEDIUM OPTIMIZATION; OPTIMAL INDUCER; PSEUDOMONAS AERUGINOSA;

BACTERIA;

BENZENE DERIVATIVE; DILTIAZEM; METHYL 3 (4 METHOXYPHENYL)GLYCIDATE; RNA 16S; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BEEF CATTLE; CONCENTRATION (PARAMETERS); ENANTIOSELECTIVITY; ENZYME SYNTHESIS; HYDROLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RNA SEQUENCE; TEMPERATURE DEPENDENCE;

BACTERIA (MICROORGANISMS); BOS TAURUS; PSEUDOMONAS AERUGINOSA;

EID: 33645414108     PISSN: 16157591     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00449-006-0052-5     Document Type: Erratum

References (13)

1. Jaeger KE, Dijkstra BW, Reetz MT (1999) Bacterial biocatalysts: molecular biology, three dimesional structures and biotechnological applications of lipases. Annu Rev Microbiol 53:315-351
2. Zaks A, Klibanov AM (1984) Enzymatic catalysis in organic media at 100°C. Science 224:1249-1251
3. Sharma R, Chisti Y, Banerjee UC (2001) Production, purification, characterization and applications of lipases. Biotechnol Adv 19:627-662
4. Nagao T, Sato M, Nakajima H, Kiyomoto A (1972) Studies on a new 1,5-benzothiazepine derivative (CRD-401). II. Vasodilator actions.Jpn J Pharmacol 22:1-10
5. Nagao T, Sato M, Nakajima H, Kiyomoto A (1973) Studies on a new 1,5-benzothiazepine derivative (CRD-401). IV. Coronary vasodilating effect and structure-activity relationship. Chem Pharm Bull 21:92-97
6. Dodds DR, Lopez JL, Zepp CM, Brandt S (2003) Process for preparing optically active glycidate esters. United States Patent number 6521445
7. Gao J, Xu JH, Li XJ, Liu ZZ (2004) Optimization of Serratia marcescens lipase production for enantioselective hydrolysis of 3-phenylglycidic acid ester. J Ind Microbiol Biotechnol 31:525-530
8. Matsumae H, Furui M, Shibatani T (1993) Lipase-catalysed asymmetric hydrolysis of 3-phenyl glycidic ester, the key intermediate in the synthesis of diltiazem hydrochloride. J Ferment Bioeng 75:93-98
9. Crotti P, Terretti M, Macchia F, Stoppioni A (1986) Ring opening reaction of cis- and trans-2,3-bis(4-methoxybenzyl)oxirane: competition between assistance and migration of an aryl group. J Org Chem 51:2759-2766
10. Sharma R, Singh S, Roy A, Chawla HPS, Kaul CL, Banerjee UC (2003) An improved process for enantioselective hydrolysis of trans-(-)-MPGM using a novel microbial lipase. Indian Patent Application No. 1358/DEL/2003
11. Singh S, Banerjee UC (2005) Enantioselective hydrolysis of methoxyphenyl glycidic acid methyl ester [(±)-MPGM] by a thermostable and alkalostable lipase from Pseudomonas aeruginosa. J Mol Catal, B Enzym 36:30-35
12. Winkler UK, Stuckmann M, (1979) Glycogen, hyaluronate, and some other polysaccharides greatly enhance the formation of exolipase by Serratia marcescens. J Bacteriol 138:663-670
13. Li CY, Cheng CY, Chen TL (2001) Production of Acinetobacter radioresistens lipase using tween-80 as the carbon source. Enzyme Microb Technol 29:258-263